D68.6
Conditions
Interventions
Group 1: Patients with confirmed antiphospholipid syndrome: classification and course of therapy, followup regarding reccurrences, thrombotic events, pregnancies by structured phone interview
Sponsors
Universitätsklinikum Frankfurt, Hämophiliezentrum
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: - confirmed diagnosis of antiphospholipid syndrome - for followup: signed consent
Exclusion criteria
Exclusion criteria: - no confirmed diagnosis of antiphospholipid syndrome - for followup: no signed consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| • APS-classification according to Sapporo/Sydney-criteria 2006 at the time of initial diagnosis • APS-classification according to 2023 ACR/EULAR and risk stratification at the time of initial diagnosis • adjusted Global Antiphospholipid Syndrome Score at the time of initial diagnosis Data will be collected from patient records. | — |
Secondary
| Measure | Time frame |
|---|---|
| • gender • age at initial APS diagnosis, rezidive • underlying disease • anamnesis, family anamnesis • further thrombophilic risk factors • Laboratory parameters at initial episode and reccurence including PTT, thrombocytes, Lupus-sensitive aPTT, Diluted Russel Viper Venom Time (DRVVT screen/ratio), anti-ß2-glycoprotein /anti- cardiolipin antibodies • symptoms • therapy • outcome • long term data about recurrence, morbidity, pregnancies | — |
Countries
Germany
Contacts
Public ContactWolfgang Miesbach
Universitätsklinikum Frankfurt, Hämophiliezentrum
Outcome results
None listed